Newsroom: Success Stories
Apellis in the Greater Zurich Area
Apellis Pharmaceuticals is an American biotech company that has established a hub in the Greater Zurich Area for all its non-US activities since the beginning of 2019. Apellis currently has more than 750 employees, including those at its headquarters in Waltham, Massachusetts. Over 30 highly experienced pharma experts are employed by Apellis Switzerland GmbH in […]
April 28, 2023
BioFi AG newly settles in Basel
BioFi has set up its headquarters in Basel. The company has emerged from Crowley Davis Research, which was established in the US state of Idaho in 2000. Using its proprietary technologies, BioFi operates the CellSim platform, which can be used to model and simulate living organisms. The newly established company BioFi AG has settled in Basel. It […]
January 11, 2023
Personalized health start-up Impli Limited brings its implantable sensor technology to Switzerland!
Lucerne – Impli, the personalized health start-up specializing in developing implantable sensors the size of a grain of rice, has chosen Technopark Lucerne to expand in continental Europe. Impli develops implantable technologies. Its first product, ImpliCaspian, was the first subdermal implant globally to be released. It is scanned using the Impli mobile application with NFC […]
April 25, 2022
Bio-pharmaceutical giant, Merck & Co. Inc. (MSD) maintains strong roots in Switzerland and continues to expand and grow in both Lucerne and Zurich
Canton Lucerne – With $48B in global Revenue (2020), Merck & Co., Inc. (a.k.a. MSD Merck Sharpe & Dohme) is a world-class, research-intensive bio-pharmaceutical company. Founded over 125 years ago in the United States, MSD is present in 140 countries with 74,000 employees as of 2020. MSD’s Swiss Branch opened in 1963 and through […]
July 22, 2021
Biogen grows international headquarters in Greater Zurich Area
Biogen is where science meets humanity. As pioneers in neuroscience, the company has developed the world’s leading portfolio of treatments for Multiple Sclerosis and developed the world’s first approved treatment for Spinal Muscular Atrophy. Today, Biogen is developing innovative treatments for Alzheimer’s Disease, ALS and many other conditions.
May 11, 2021
Roivant established its global headquarters in the Basel Area
Roivant, valued $7 Billion, in the Basel Area. “Basel is emblematic in that sense because it brings together a very diverse talent pool from multiple countries and cultures, speaking different languages with varied experiences and educational backgrounds”, says Vivek Ramaswamy, Founder and CEO.
May 11, 2021
California-based Align Technology selects Greater Zurich Area for European headquarters
Align Technology is a leading medical device company in the dental industry with headquarters in California and over 17,000 employees worldwide. It has set the bar for leadership and change in dental industry by constantly innovating to bring new and better solutions to doctors and their patients. To further expand and develop their products, the company moved its regional headquarters from Amsterdam to Rotkreuz in the Greater Zurich Area. The new office with over 150 employees opened in January 2020 and will also serve as R&D hub.
March 15, 2021
Moderna established European headquarters in Switzerland
Moderna, one of the leading biotech companies in the fight against covid-19, established their European headquarters in Basel. “Basel offers access to companies from the pharmaceutical, biotechnology and special ingredients markets. Those companies combine technological innovation with world-class production and process excellence.
March 15, 2021
Women’s Health focused company chooses Lucerne, Switzerland
This past February 2021, Merck & Co. established the Headquarters for Organon & Co. a standalone, spin-off company dedicated to global leadership in women’s health. This move adds 150-200 jobs to Lucerne’s biopharma ecosystem.
January 27, 2021
Novocure cancer therapy chooses Lucerne for Swiss EMEA Headquarters
Novocure is a commercial-stage oncology company dedicated to the advancement of TTF therapy (Tumor Treating Fields) for patients with solid tumors.
January 1, 2021
Switzerland-based data-driven medicine leader raises $110 million
Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for data-driven medicine worldwide.
October 6, 2020
Neubio produces innovative cochlear implants in Biel
Hailing from the United States, the start-up established its global headquarters in Biel in May 2017 to manufacture and sell cochlear implants and hearing aids for the worldwide hearing-impaired market.
June 7, 2018